Clene Nanomedicine Revenue and Competitors
Estimated Revenue & Valuation
- Clene Nanomedicine's estimated annual revenue is currently $15.5M per year.
- Clene Nanomedicine's estimated revenue per employee is $201,000
Employee Data
- Clene Nanomedicine has 77 Employees.
- Clene Nanomedicine grew their employee count by -3% last year.
Clene Nanomedicine's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | Chief Development Officer | Reveal Email/Phone |
3 | Chief Science Officer | Reveal Email/Phone |
4 | CFO | Reveal Email/Phone |
5 | VP Quality and Technical Operations | Reveal Email/Phone |
6 | VP, Translational Medicine | Reveal Email/Phone |
7 | VP R&D | Reveal Email/Phone |
8 | Head Medical | Reveal Email/Phone |
9 | VP, Translational Medicine | Reveal Email/Phone |
10 | VP, Quality & Technical Operations | Reveal Email/Phone |
Clene Nanomedicine Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $8.2M | 41 | -11% | N/A | N/A |
#2 | $18.3M | 91 | 6% | N/A | N/A |
#3 | $20.5M | 102 | 0% | N/A | N/A |
#4 | $8.4M | 42 | 11% | N/A | N/A |
#5 | $18.1M | 90 | 38% | N/A | N/A |
#6 | $12.9M | 64 | 21% | N/A | N/A |
#7 | $5.6M | 28 | -10% | N/A | N/A |
#8 | $51.9M | 258 | 25% | N/A | N/A |
#9 | $7.2M | 36 | 6% | N/A | N/A |
#10 | $7.2M | 36 | 33% | N/A | N/A |
What Is Clene Nanomedicine?
Clene Nanomedicine, Inc. is a privately-held, clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally-administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland. This is an exciting time for us. We have been receiving many requests for more information. We hope you understand we cannot respond to individual requests. We instead invite you to visit our website, read our press releases, and check back for updates. For more information, please visit www.clene.com.
keywords:N/AN/A
Total Funding
77
Number of Employees
$15.5M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clene Nanomedicine News
The nanotherapeutic CNM-Au8 (Clene Nanomedicine) is currently in development for treatment of patients with ALS, MS and Parkinson's disease.
Clene is a clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative disease by targeting energetic...
Updated Interim Data from Clene Nanomedicine's RESCUE-ALS Open-Label Extension Study to be Presented in Emerging Science Program at 2022 AAN...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 77 | 20% | N/A |
#2 | $7.5M | 77 | 10% | N/A |
#3 | $13.5M | 77 | 54% | N/A |
#4 | $20.8M | 77 | 7% | N/A |
#5 | $25.3M | 77 | 20% | N/A |